MedTrace Logo

To Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

NCT04584736 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 283

Last updated 2021-12-01

No results posted yet for this study

Summary

To Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia.

Conditions

  • Primary Hypercholesterolemia

Interventions

DRUG

Livalo, Ezetrol

Pitavastatin+Ezetimibe Pitavastatin

Sponsors & Collaborators

Principal Investigators

  • dongryeong lee, Manager · +82-2-840-6982

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
19 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-11
Primary Completion
2020-07-16
Completion
2020-10-12

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04584736 on ClinicalTrials.gov